| scholarly article | Q13442814 |
| P2093 | author name string | Karina J Yoon | |
| Elizabeth A Beierle | |||
| Jerry E Stewart | |||
| Laura L Stafman | |||
| Laura V Bownes | |||
| Adele P Williams | |||
| Raoud Marayati | |||
| Colin H Quinn | |||
| Jamie M Aye | |||
| Venkatram Atigadda | |||
| P2860 | cites work | CDK5RAP2 is required for spindle checkpoint function | Q24321342 |
| Cancer Stem Cells and Their Interaction with the Tumor Microenvironment in Neuroblastoma | Q26771238 | ||
| Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and Cancer | Q26800202 | ||
| Nestin as a marker of cancer stem cells | Q26851514 | ||
| Retinoids induce cellular senescence in breast cancer cells by RAR-β dependent and independent pathways: Potential clinical implications (Review) | Q28081010 | ||
| Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance | Q28282963 | ||
| Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression | Q43831014 | ||
| Whole exome sequencing identified sixty-five coding mutations in four neuroblastoma tumors. | Q47134349 | ||
| Human GAP-43 Gene Expression: Multiple Start Sites for Initiation of Transcription in Differentiating Human Neuroblastoma Cells | Q47818211 | ||
| Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials. | Q47834857 | ||
| Patient-derived xenografts as preclinical neuroblastoma models. | Q50027944 | ||
| The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis. | Q52337679 | ||
| Neuroblastoma: clinical and biological approach to risk stratification and treatment. | Q52639269 | ||
| High-Risk Neuroblastoma Treatment Review | Q57167141 | ||
| Corruption of neuroblastoma patient derived xenografts with human T cell lymphoma | Q58582006 | ||
| Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice | Q58797496 | ||
| Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells | Q73797274 | ||
| Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein | Q73816993 | ||
| The role of cellular motility in the invasion of human neuroblastoma cells with or without N-myc amplification and expression | Q77736685 | ||
| A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro | Q89118592 | ||
| Cancer stem cells and differentiation therapy | Q89738365 | ||
| Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts | Q90100923 | ||
| Neuroblastoma Origin and Therapeutic Targets for Immunotherapy | Q90993007 | ||
| UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts | Q91072445 | ||
| Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy | Q92527643 | ||
| Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier | Q92698902 | ||
| Ultrastructural features of a human neuroblastoma cell line treated with retinoic acid | Q93559405 | ||
| Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus | Q28474594 | ||
| Retinoic acid reduces human neuroblastoma cell migration and invasiveness: effects on DCX, LIS1, neurofilaments-68 and vimentin expression. | Q33317070 | ||
| Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. | Q33931217 | ||
| Differentiating agents in pediatric malignancies: retinoids in neuroblastoma. | Q34108090 | ||
| Coordinating cell proliferation and differentiation | Q34132852 | ||
| Cell cycle and cell fate in the nervous system. | Q34141459 | ||
| Progression from extrinsic to intrinsic signaling in cell fate specification: a view from the nervous system | Q34492474 | ||
| Characteristics of stem cells from human neuroblastoma cell lines and in tumors | Q34928930 | ||
| Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma | Q34978580 | ||
| Retinoid therapy of high-risk neuroblastoma. | Q35184993 | ||
| Src is a novel potential off-target of RXR agonists, 9-cis-UAB30 and Targretin, in human breast cancer cells | Q35470139 | ||
| A pilot, first-in-human, pharmacokinetic study of 9cUAB30 in healthy volunteers | Q35482306 | ||
| Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma | Q35832541 | ||
| Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. | Q35893158 | ||
| Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation | Q35931312 | ||
| Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group | Q36010031 | ||
| Effects on gene expression in rat liver after administration of RXR agonists: UAB30, 4-methyl-UAB30, and Targretin (Bexarotene). | Q36642371 | ||
| Valproic acid overcomes hypoxia-induced resistance to apoptosis. | Q36642574 | ||
| Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas | Q36762610 | ||
| Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies | Q36917809 | ||
| Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells | Q37349093 | ||
| Role of stemness-related molecules in neuroblastoma | Q37995020 | ||
| Neuroblastoma stem cells - mechanisms of chemoresistance and histone deacetylase inhibitors. | Q38031959 | ||
| Induced differentiation inhibits sphere formation in neuroblastoma | Q38764733 | ||
| CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway | Q39384559 | ||
| HOXC9 links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma | Q39555632 | ||
| Comparison of the Side Populations in Pretreatment and Postrelapse Neuroblastoma Cell Lines | Q39670555 | ||
| Quantitative assessment of neurite outgrowth in human embryonic stem cell-derived hN2 cells using automated high-content image analysis | Q39734349 | ||
| Resistance of stem-like cells from neuroblastoma cell lines to commonly used chemotherapeutic agents | Q39772497 | ||
| Retinoic acid downregulates Rae1 leading to APC(Cdh1) activation and neuroblastoma SH-SY5Y differentiation | Q40021807 | ||
| Factors associated with recurrence and survival length following relapse in patients with neuroblastoma | Q40518791 | ||
| Nestin is a potential mediator of malignancy in human neuroblastoma cells | Q40561244 | ||
| Expression of class III beta-tubulin in normal and neoplastic human tissues | Q41051476 | ||
| Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro | Q41665140 | ||
| Neurite outgrowth and cell cycle kinetic changes induced by cis-diamminedichloroplatinum II and retinoic acid in a human neuroblastoma cell line. | Q41727824 | ||
| 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group. | Q41950761 | ||
| CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma Cells | Q42227825 | ||
| Combination therapies improve the anticancer activities of retinoids in neuroblastoma | Q43134812 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P921 | main subject | neuroblastoma | Q938205 |
| P304 | page(s) | 100893 | |
| P577 | publication date | 2020-09-30 | |
| P1433 | published in | Translational Oncology | Q26839583 |
| P1476 | title | 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts | |
| P478 | volume | 14 |
Search more.